Medfinder
Back to blog

Updated: January 16, 2026

Trimo-San Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Calendar with medication bottle and availability graph

Trimo-San isn't in an FDA shortage, but it's still hard to find at many pharmacies. Here's the 2026 update on Trimo-San availability and what patients can do.

If you've had trouble filling a Trimo-San prescription in 2026, you may have heard the word "shortage" thrown around. Here's what the data actually shows — and what it means for you as a patient.

Is Trimo-San in an Official FDA Shortage in 2026?

No. As of 2026, Trimo-San (oxyquinoline sulfate / sodium lauryl sulfate vaginal jelly) is not listed on the FDA's official drug shortage database. It has not been on the FDA shortage list historically either. There is no formal, nationally declared shortage of this medication.

However, the absence of an FDA shortage designation does not mean it's easy to find. Many patients report difficulty filling their Trimo-San prescriptions — and this has been an ongoing, structural challenge rather than a sudden shortage event.

Why Is Trimo-San Hard to Find If It's Not in Shortage?

The difficulty finding Trimo-San comes down to several structural factors:

  • No generic version exists. Trimo-San is brand-name only. No lower-cost generic has entered the market, limiting the number of distributors and pharmacies that carry it.
  • Not FDA-approved. Trimo-San is an unapproved drug that remains on the market because there is no FDA-approved equivalent for its specific use. This unusual status limits its mainstream pharmacy stocking.
  • Insurance rarely covers it. Medicare Part D and many private insurance plans do not cover Trimo-San. Lower covered-patient volume means pharmacies have less incentive to keep it in stock.
  • Niche patient population. Trimo-San is primarily prescribed for pessary users — a specific population that is not large enough to drive high-volume pharmacy stocking decisions.

What Is the Current Availability of Trimo-San in 2026?

Trimo-San (0.025%-0.01% vaginal jelly in 113.4g, 226.8g, and 340.2g tube sizes) is available in the United States. It can be found at select locations of major chains including CVS, Walgreens, Walmart Pharmacy, and Kroger — but not all locations carry it. Independent pharmacies and specialty compounding pharmacies may be additional sources.

The retail cash price for Trimo-San remains around $37–$58 for a 113.4g tube. With GoodRx or SingleCare coupons, the price can be reduced to approximately $29–$33 per tube.

What Should You Do If You Can't Find Trimo-San?

If your pharmacy doesn't have Trimo-San in stock, try these steps: First, use medfinder to have pharmacies called on your behalf to find which ones have it available. Second, ask your pharmacy if they can special-order it (most can within 1–3 business days). Third, consider whether an alternative product might work — see our guide to Trimo-San alternatives and discuss options with your provider.

What Patients Are Saying About Trimo-San Availability in 2026

Many patients who rely on Trimo-San for pessary care report that their experience varies significantly by region and pharmacy chain. Some have found it consistently at one specific pharmacy location; others have had to call multiple pharmacies before finding it or wait for a special order. This inconsistency is frustrating for a medication that needs to be used on a regular schedule (typically twice a week for long-term pessary users).

Will Trimo-San Availability Improve?

Because the scarcity of Trimo-San at individual pharmacies is structural rather than crisis-driven, significant improvements in availability are likely only if the product gains wider pharmacy distribution, if a generic enters the market, or if an FDA-approved alternative with broader stocking gains traction. For now, patients should plan ahead, maintain a relationship with a pharmacy that reliably stocks it, and use tools like medfinder to find it quickly when needed.

Frequently Asked Questions

No. Trimo-San is not on the FDA's official drug shortage list in 2026. However, it is a brand-name only, unapproved product with limited pharmacy distribution, making it genuinely difficult to find at many locations.

There is no documented history of Trimo-San appearing on the FDA's official drug shortage database. The difficulty finding it is a structural issue related to its brand-only status, limited insurance coverage, and niche patient population — not a shortage event.

The retail cash price for Trimo-San 113.4g tube is approximately $37–$58 in 2026. With discount cards like GoodRx or SingleCare, the price can be reduced to around $29–$33 per tube. Medicare and most insurance plans do not cover it.

There is currently no generic version of Trimo-San and no publicly known plans for one to enter the market. Because Trimo-San is not FDA-approved, the standard generic drug approval pathway (ANDA) does not directly apply, making generic development unlikely in the near term.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Trimo-San also looked for:

35,931 have already found their meds with Medfinder.

Start your search today.

35K+
5-star ratingTrusted by 35,931 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?